Ledger.Open graph →

SEC Form D · filed November 22, 2021

Vergent Bioscience, Inc

Offering

$2.0M

Sold

$1.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

MINNEAPOLIS, MN

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Ryan D. Egeland · MINNEAPOLIS, MNDirector Douglas D. Kohrs · MINNEAPOLIS, MNDirector John Santini · MINNEAPOLIS, MNExec · Director Jeffrey D. Yurecko · MINNEAPOLIS, MNExec Jeffrey Julkowski · MINNEAPOLIS, MNDirector · Promoter Raymond D. Wong · MINNEAPOLIS, MNDirector Samuel D. Banks · MINNEAPOLIS, MNDirector David R. Schwartz · CHICAGO, ILDirector · Promoter Kyle Volluz · Dallas, TXExec Elizabeth C. Fujino · Westlake Village, CADirector Peter W. Mooradian · Boston, MADirector Patrick Arippol · Sao Paulo, GuernseyDirector Philip H. Lukowski · CHICAGO, ILExec · Director John C. Hansen · Westlake Village, CADirector Curtis Floyd · BAKERSFIELD, CADirector Bruce Beretta · BAKERSFIELD, CADirector Kevin S. Little · Boca Raton, FLDirector · Promoter NEF Assignment Corporation · Chicago, ILExec · Director Jason Castle · BAKERSFIELD, CADirector Paramijt Dosanjh · BAKERSFIELD, CAExec Alison Forsyth · Somerville, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗